| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/28/2009 | WO2009065604A2 Pharmaceutical composition comprising glucosamine sulfate, chondroitine sulfate and ibuprofene |
| 05/28/2009 | WO2009065296A1 Gene engineering immunorepressive polypeptides and their preparing methods and uses |
| 05/28/2009 | WO2009010968A3 Disease treatment via antimicrobial peptides or their inhibitors |
| 05/28/2009 | US20090137845 Novel 4-Dedimethylaminotetracycline derivatives |
| 05/28/2009 | US20090137678 High yield synthesis methods for producing organic salts of strontium |
| 05/28/2009 | US20090137631 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression |
| 05/28/2009 | US20090137604 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 05/28/2009 | US20090137603 Heterocyclic amide compound and use thereof |
| 05/28/2009 | US20090137581 Heterocyclic compounds and their uses |
| 05/28/2009 | US20090137557 Calcilytic Compounds |
| 05/28/2009 | US20090137549 Novel compounds useful for the treatment of degenerative & inflamatory diseases |
| 05/28/2009 | US20090137536 Method for treating and preventing hyperparathyroidism |
| 05/28/2009 | US20090137513 RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/28/2009 | US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases |
| 05/28/2009 | US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 05/28/2009 | US20090137482 Biologically active peptide and agent containing the same |
| 05/28/2009 | US20090137480 Transdermal delivery system for dried particulate or lyophilized medications |
| 05/28/2009 | US20090137476 Apo-2 ligand variants and uses thereof |
| 05/28/2009 | US20090136511 an oligopeptide capable of binding cellular IL-15R alpha or its soluble fraction and inhibiting IL-15-dependent T cell proliferation activity, used for treating rheumatoid arthritis and psoriasis in a mammal; immunogens |
| 05/28/2009 | US20090136507 HBM variants that modulate bone mass and lipid levels |
| 05/28/2009 | US20090136491 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/28/2009 | DE102007056424A1 Pharmazeutische Zusammensetzung, enthaltend eine Öl/Wasser-Emulsion A pharmaceutical composition containing an oil / water emulsion |
| 05/28/2009 | DE102007056253A1 Use of homogenized sloe composition, obtained by heating, e.g. for liquefaction of body fluids, reduction of surface tension, for the reduction of body odor, preferably excrement and sweat, to promote hair growth and as antibiotic |
| 05/28/2009 | CA2706882A1 Bone morphogenic protein binding peptide |
| 05/28/2009 | CA2706536A1 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
| 05/28/2009 | CA2705599A1 New compounds |
| 05/28/2009 | CA2705596A1 New compounds |
| 05/28/2009 | CA2705405A1 New compounds |
| 05/28/2009 | CA2704883A1 New compounds |
| 05/27/2009 | EP2062914A2 Somatostatin-dopamine chimeric analogs |
| 05/27/2009 | EP2062889A1 Compounds |
| 05/27/2009 | EP2062879A1 Heterocyclic inhibitors of p38 |
| 05/27/2009 | EP2062595A1 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 05/27/2009 | EP2062584A1 Adhesive preparation |
| 05/27/2009 | EP2062583A2 Therapeutic applications of pro-apoptotic benzodiazepines |
| 05/27/2009 | EP2062577A1 Oleanolic acid derivatives as NO production inhibitors |
| 05/27/2009 | EP2061812A1 Method for producing antibodies |
| 05/27/2009 | EP2061759A1 Cyclic modulators of chemokine receptor activity |
| 05/27/2009 | EP2061457A1 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of cartilage degradation or cartilage damage in joints |
| 05/27/2009 | EP2061446A2 Use of cdk inhibitors for the treatment of granulocyte mediated disorders |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1351672B1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP1171424B1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 05/27/2009 | EP1037651B1 Small peptides and methods for treatment of asthma and inflammation |
| 05/27/2009 | CN201244205Y Dual-purpose patches for external use |
| 05/27/2009 | CN101443000A Xanthone derivative for the treatment of muscular disorders |
| 05/27/2009 | CN101440343A Bitter melon health wine and preparation method thereof |
| 05/27/2009 | CN101440029A Method for extracting xanthohumol from lupulus |
| 05/27/2009 | CN101439173A Chinese medicine prescription for treating rheumatic arthritis |
| 05/27/2009 | CN101439165A Plaster for treating bone fracture and preparation method thereof |
| 05/27/2009 | CN101439136A Plaster for treating bone disease and soft tissue injury |
| 05/27/2009 | CN101439128A Technique for preparing Linggui plaster |
| 05/27/2009 | CN101439127A Pharmaceutical product for treating fracture |
| 05/27/2009 | CN101439110A Chinese medicine for curing rheumatism |
| 05/27/2009 | CN101439102A 'Mashe' oil rheumatalgia-relieving plaster |
| 05/27/2009 | CN101439069A Leaf extract of Herba siegesbeckiae, preparation method and uses thereof |
| 05/27/2009 | CN101439061A Chinese herbal medicine for bathing foot |
| 05/27/2009 | CN101438823A Health-care bag tea for reducing uric acid and preparation method thereof |
| 05/27/2009 | CN100491532C Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 05/27/2009 | CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors |
| 05/27/2009 | CN100491368C Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/27/2009 | CN100491362C Biologically active methylene blue derivatives |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/27/2009 | CN100490900C Composition for the carrying and delivery of bone growth inducing material and methods for producing and applying the composition |
| 05/27/2009 | CN100490893C Osteogenic composition |
| 05/27/2009 | CN100490880C Chinese medicinal composition for treating rheumatic and rheumatoid arthritis |
| 05/27/2009 | CN100490844C Medicinal composition for treating hyperuricemia and gouty nephropthy |
| 05/27/2009 | CN100490836C Medicine composition for treating osseous arthritis, and its preparation method |
| 05/27/2009 | CN100490835C Medication for quick setting a broken bone |
| 05/27/2009 | CN100490811C Piperazine derivative used as CCRS antagonist |
| 05/27/2009 | CN100490804C Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 05/27/2009 | CN100490791C Compositions and methods to treat neovascularization and disease associated with thereof |
| 05/26/2009 | US7538118 6-aminomorphinane derivatives, method for production and use thereof |
| 05/26/2009 | US7538089 Anti-inflammatory compounds and uses thereof |
| 05/26/2009 | US7537887 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 05/26/2009 | CA2497857C Novel p-selectin ligand protein |
| 05/26/2009 | CA2494165C Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 05/26/2009 | CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists |
| 05/26/2009 | CA2436668C Novel succinate salt of o-desmethyl-venlafaxine |
| 05/26/2009 | CA2387201C Tetrahydroquinoline derivatives |
| 05/26/2009 | CA2367017C Inhibitors of impdh enzyme |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/26/2009 | CA2254420C Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 05/22/2009 | WO2009064938A1 Method of treating arthritis |
| 05/22/2009 | WO2009064431A1 Methods of use |
| 05/22/2009 | WO2009064399A1 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 05/22/2009 | WO2009064251A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | WO2009064250A1 Bis-(sulfonylamino) derivatives in therapy 065 |
| 05/22/2009 | WO2009063993A1 Fused pyridine derivative and use thereof |
| 05/22/2009 | WO2009063990A1 Benzazepinone compound |
| 05/22/2009 | WO2009063885A1 Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan) |
| 05/22/2009 | WO2009063872A1 Pseudoginseng extract |
| 05/22/2009 | WO2009063836A1 Process for production of polyphenol extract, prophylactic agent for osteoporosis, saccharide-digesting enzyme inhibitor, functional composition comprising the polyphenol extract, and food composition, food composition for specified health uses, quasi drug composition and pharmaceutical composition each comprising the functional composition |
| 05/22/2009 | WO2009062683A1 C-19 steroids for therapeutic uses |
| 05/22/2009 | WO2009062662A1 Pharmaceutical and nutraceutical compositions based on menaquinols |
| 05/22/2009 | WO2008092591A9 Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent |
| 05/22/2009 | WO2008034032A3 Beta-lactam cannabinoid receptor modulators |